![Remi Gaston-Dreyfus](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Remi Gaston-Dreyfus
Direktor/Vorstandsmitglied bei BIONIK LABORATORIES CORP.
Vermögen: 689 550 $ am 30.09.2023
Aktive Positionen von Remi Gaston-Dreyfus
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
BIONIK LABORATORIES CORP. | Direktor/Vorstandsmitglied | 01.09.2017 | - |
Independent Dir/Board Member | 01.09.2017 | - | |
RGD Investissements SAS
![]() RGD Investissements SAS Miscellaneous Commercial ServicesCommercial Services RGD Investissements SAS provides business and management consulting services. The private company is based in Paris, France. The French company was founded by Remi Gaston-Dreyfus. Remi Gaston-Dreyfus has been the CEO since incorporation. | Vorstandsvorsitzender | 01.01.2007 | - |
Gründer | 01.01.2007 | - | |
BIONIK, Inc.
![]() BIONIK, Inc. Industrial MachineryProducer Manufacturing Part of Bionik Laboratories Corp., BIONIK, Inc. designs, develops and markets robotic tools for neurorehabilitation professionals, and patients and their families. The company is based in Watertown, MA. The company was founded by Michael Prywata. | Direktor/Vorstandsmitglied | 01.09.2017 | - |
GDG Investissemts
![]() GDG Investissemts Real Estate DevelopmentFinance Part of GD Holding SARL, GDG Investissements is a real estate investment company based in Paris, France. GDG Investissements is a multidisciplinary team of professionals who work together to deliver high-quality, high-performance real estate assets. The French company specializes in the renovation and restructuring of real estate assets. The company was founded in 2006. Remi Gaston-Dreyfus has been the CEO of the company since 2007. | Vorstandsvorsitzender | 01.01.2007 | - |
Vorsitzender | 01.01.2007 | - | |
Linkinvax SA
![]() Linkinvax SA Miscellaneous Commercial ServicesCommercial Services Linkinvax SA is a French company founded in 2020 by Remi Gaston-Dreyfus, Yves Lévy, André-Jacques Auberton-Hervé, Laurent Hanot, and Mireille Centlivre. The company is based in Paris, France. Linkinvax is developing an innovative protein-based vaccine platform that can accelerate the availability of vaccines by leveraging the research conducted at the Vaccine Research Institute (VRI). The platform is DC targeting-based and can adapt to changes and mutations in the target pathogens. Linkinvax aims to revolutionize vaccine development, particularly for new viruses like Chlamydia and COVID-19. The company is led by André-Jacques Auberton-Hervé, who has been the CEO since 2020. | Direktor/Vorstandsmitglied | 01.01.2020 | - |
Gründer | 01.01.2020 | - |
Karriereverlauf von Remi Gaston-Dreyfus
Ehemalige bekannte Positionen von Remi Gaston-Dreyfus
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Christie's International Plc
![]() Christie's International Plc Specialty StoresRetail Trade Christie's International Plc provides art business services with global auction sales. Its services include corporate collections, heritage and taxation, storage, museum, and private sales, as well as estates, appraisals, and valuations. The firm serves in the areas of fine and decorative arts, jewelry, photographs, collectibles and wines. The company was founded by James Christie in 1766 and is headquartered in London, the United Kingdom. | Direktor/Vorstandsmitglied | 01.01.2014 | - |
Statistik
International
Frankreich | 4 |
Vereinigte Staaten | 3 |
Vereinigtes Königreich | 2 |
Operativ
Director/Board Member | 4 |
Chief Executive Officer | 2 |
Founder | 2 |
Sektoral
Commercial Services | 3 |
Health Technology | 2 |
Retail Trade | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
BIONIK LABORATORIES CORP. | Health Technology |
Private Unternehmen | 5 |
---|---|
RGD Investissements SAS
![]() RGD Investissements SAS Miscellaneous Commercial ServicesCommercial Services RGD Investissements SAS provides business and management consulting services. The private company is based in Paris, France. The French company was founded by Remi Gaston-Dreyfus. Remi Gaston-Dreyfus has been the CEO since incorporation. | Commercial Services |
Christie's International Plc
![]() Christie's International Plc Specialty StoresRetail Trade Christie's International Plc provides art business services with global auction sales. Its services include corporate collections, heritage and taxation, storage, museum, and private sales, as well as estates, appraisals, and valuations. The firm serves in the areas of fine and decorative arts, jewelry, photographs, collectibles and wines. The company was founded by James Christie in 1766 and is headquartered in London, the United Kingdom. | Retail Trade |
BIONIK, Inc.
![]() BIONIK, Inc. Industrial MachineryProducer Manufacturing Part of Bionik Laboratories Corp., BIONIK, Inc. designs, develops and markets robotic tools for neurorehabilitation professionals, and patients and their families. The company is based in Watertown, MA. The company was founded by Michael Prywata. | Producer Manufacturing |
GDG Investissemts
![]() GDG Investissemts Real Estate DevelopmentFinance Part of GD Holding SARL, GDG Investissements is a real estate investment company based in Paris, France. GDG Investissements is a multidisciplinary team of professionals who work together to deliver high-quality, high-performance real estate assets. The French company specializes in the renovation and restructuring of real estate assets. The company was founded in 2006. Remi Gaston-Dreyfus has been the CEO of the company since 2007. | Finance |
Linkinvax SA
![]() Linkinvax SA Miscellaneous Commercial ServicesCommercial Services Linkinvax SA is a French company founded in 2020 by Remi Gaston-Dreyfus, Yves Lévy, André-Jacques Auberton-Hervé, Laurent Hanot, and Mireille Centlivre. The company is based in Paris, France. Linkinvax is developing an innovative protein-based vaccine platform that can accelerate the availability of vaccines by leveraging the research conducted at the Vaccine Research Institute (VRI). The platform is DC targeting-based and can adapt to changes and mutations in the target pathogens. Linkinvax aims to revolutionize vaccine development, particularly for new viruses like Chlamydia and COVID-19. The company is led by André-Jacques Auberton-Hervé, who has been the CEO since 2020. | Commercial Services |
- Börse
- Insiders
- Remi Gaston-Dreyfus
- Erfahrung